Does Intravenous Prochlorperazine Cause Local Irritation or Phlebitis?
Yes, intravenous prochlorperazine can cause local irritation, and subcutaneous administration is specifically contraindicated due to this risk, though phlebitis is not commonly reported as a major adverse effect with proper IV administration. 1
Key Administration Guidance
The FDA label explicitly warns about local irritation with prochlorperazine:
- Subcutaneous administration is NOT advisable because of local irritation 1
- For intramuscular use, the label notes that "pain and irritation at the site of injection have seldom occurred" 1
- IV administration should be by slow injection at a rate not exceeding 5 mg per minute - never as bolus injection 1
- The drug may be given undiluted or diluted in isotonic solution 1
Proper IV Technique to Minimize Irritation
To avoid local complications:
- Administer as slow IV injection or infusion (maximum 5 mg/minute) 1
- Do not exceed 10 mg per single dose IV 1
- Total daily IV dosage should not exceed 40 mg 1
- Avoid bolus injection technique 1
Important caveat: Contact dermatitis is possible - avoid getting the injection solution on hands or clothing 1. This underscores the drug's irritant properties.
Clinical Evidence on Administration Rate
Research comparing 2-minute bolus versus 15-minute infusion found no difference in the primary outcome studied (akathisia), suggesting both methods are feasible from a tolerability standpoint 2. However, the FDA label's explicit prohibition of bolus injection and requirement for slow administration should take precedence over this research finding.
Common Pitfalls
The main risk is hypotension with IV administration, not phlebitis 1. The irritation concern is primarily relevant for:
- Subcutaneous routes (contraindicated)
- Extravasation (avoid by ensuring proper IV access)
- Rapid bolus administration (contraindicated)
Bottom line: When administered properly via slow IV injection or infusion through a patent IV line, local irritation and phlebitis are not major concerns. The irritant properties manifest primarily with subcutaneous administration or improper technique.